Urte Gayko - 03 Jan 2022 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Director
Signature
/s/ Urte Gayko
Issuer symbol
SMMT
Transactions as of
03 Jan 2022
Net transactions value
+$48,085
Form type
4
Filing time
05 Jan 2022, 15:07:22 UTC
Previous filing
16 Nov 2021
Next filing
26 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +25,000 25,000 03 Jan 2022 Common Stock 25,000 $2.82 Direct F1, F2
transaction SMMT Stock Option (right to buy) Award $48,085 +42,553 +170% $1.13 67,553 03 Jan 2022 Common Stock 42,553 $2.82 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.
F2 Not applicable.
F3 The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.
F4 The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $48,000.